CIK 0001472091 · Non-accelerated filer<br>Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264231384
- Phone
- 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-18 | Dawson John Andrew Director | Grant or award · Stock Option (Right to Buy) | +22,700 | 22,700 | ||
| 2026-10-18 | Ramsdell Deborah Director | Grant or award · Stock Option (Right to Buy) | +22,700 | 22,700 | ||
| 2026-10-18 | Wendel Bruce Director | Grant or award · Stock Option (Right to Buy) | +22,700 | 22,700 | ||
| 2026-01-12 | BEDU-ADDO FRANK President/CEO | Grant or award · Employee Stock Option (Right to Buy) | +548,782 | 548,782 | ||
| 2026-01-12 | CONN GREGORY Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2026-01-12 | Shepard Kirk V. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2026-01-12 | Boesgaard Lars Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2026-01-12 | Brown Spencer D. Senior VP, General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2026-01-12 | Toutain Stephan Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2026-01-12 | Freitag Gregory Gene Director | Grant or award · Employee Stock Option (Right to Buy) | +54,876 | 54,876 | ||
| 2026-01-12 | Iliev Ilian Director | Grant or award · Employee Stock Option (Right to Buy) | +54,876 | 54,876 | ||
| 2026-01-12 | Ali-Jackson Kamil Director | Grant or award · Employee Stock Option (Right to Buy) | +54,876 | 54,876 | ||
| 2026-01-12 | BRAWLEY OTIS W Director | Grant or award · Employee Stock Option (Right to Buy) | +54,876 | 54,876 | ||
| 2026-01-12 | Glover Stephen C. Director | Grant or award · Employee Stock Option (Right to Buy) | +54,876 | 54,876 | ||
| 2025-06-12 | BEDU-ADDO FRANK President/CEO | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-06-12 | Shepard Kirk V. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-06-12 | Brown Spencer D. Senior VP, General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-06-12 | Boesgaard Lars Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-06-12 | CONN GREGORY Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-12 | Toutain Stephan Chief Operations Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 |
Page 1 of 6 · 118 trades